Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECS II and TTPB vs ESPB for Post-op Analgesia in Breast Surgery
NCT06783764Phase 4Active, not recruiting
- Sponsor
- Ain Shams University
- Start
- May 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Nalbuphine consumption in the first 24 hours post-operative. Started May 2024; status: active, not recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06783764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06783764.